InVitro International

Recent News

  • IVRO Continues to Help Make Non-Animal Testing Famous, Releases Fiscal 2022 Results

    Placentia, California--(Newsfile Corp. - December 8, 2022) - InVitro International (OTC Pink: IVRO) today announced full year FY2022 sales results of $853,511 (-15%) and net income of $21,276 (-79%).CEO W. Richard Ulmer remarked: "We remain extremely enthusiastic regarding the future of NON-Animal testing despite somewhat disappointing, Covid related, FY '22 financial results. Our October '22 announcement of a Letter of Intent to merge with a well-established, privately owned laboratory adds greatly to our belief than animal testing will continue to...

    2022-12-08 9:00 AM EST
  • IVRO Explores Opportunity for Growth

    Placentia, California--(Newsfile Corp. - November 16, 2022) - InVitro International (OTC Pink: IVRO) today announced it has signed its first Letter of Intent (LOI) to acquire a privately owned, U.S. based testing laboratory. Over many years this laboratory has served IVRO targeted markets profitably and its principals agree that the future is bright for NON-Animal testing. CEO and Board Chairman, Rich Ulmer, opined, "Following our mission to Make NON-Animal Testing Famous, this initial acquisition effort may be viewed as a...

    2022-11-16 9:00 AM EST
  • IVRO Continues to Help Make Non-Animal Testing Famous, Releases Fiscal Q3 2022 Results

    Placentia, California--(Newsfile Corp. - August 10, 2022) - InVitro International (OTC Pink: IVRO) today announced year to date Fiscal Year '22, and 3rd quarter financial results. Following a 2nd fiscal quarter sales advance of 27%, 3rd quarter sales slid 23%, leaving year to date sales at -4.9%. Net ordinary income of $11.8K in this fiscal quarter moved YTD net income to $3,349. As previously noted, a GAAP change now requires total net income reported quarterly to include investment gains and...

    2022-08-10 9:00 AM EDT
  • IVRO with a Mission to Help Make Non-Animal Testing Famous, Releases Fiscal Q2 2022 Results

    Placentia, California--(Newsfile Corp. - April 26, 2022) - InVitro International (OTC PINK: IVRO), an established leader in advancing NON-Animal testing technologies, today announced fiscal 2022 year to date and second fiscal quarter financial results. Second quarter sales of $260,219 were up 27% over the same quarter last year; this increased year to date sales to $443,780, now 9.2% ahead of fiscal 2021 sales for the first half. Second quarter suffered a net loss of $24,636 due in large part...

    2022-04-26 9:00 AM EDT
  • Stock Repurchase by IVRO's Management Shows Increased Confidence in Future of Non-Animal Testing

    Placentia, California--(Newsfile Corp. - March 30, 2022) - InVitro International (OTC PINK: IVRO), a 30+ year leader in providing non-animal testing methods, today announced it has completed the re-purchase of 100,000 shares of its common stock. The terms of this transaction were negotiated in December 2021 with a long-term shareholder.IVRO President, Atul Jhalani, said "I believe our decision reflects IVRO management's continuing strong belief in the future of NON-Animal testing; worthy of special note, just recently "The Humane Cosmetics Act...

    2022-03-30 8:40 AM EDT
  • IVRO with a Mission to Help Make Non Animal Testing Famous, Releases Fiscal Q1 2022 Results

    Placentia, California--(Newsfile Corp. - February 14, 2022) - InVitro International (OTC Pink: IVRO), a leading provider of non-animal testing methods, today announced revenues of $183,561 and net income of $56,940 for its first fiscal quarter of 2022, ending December 31, 2021, compared to revenues and net income of $201,255 and $67,663, respectively, for its first fiscal quarter of 2021. The first fiscal quarter of 2022 earnings benefitted from its second government PPP loan forgiveness much as it did in first...

    2022-02-14 8:13 AM EST
  • IVRO with a Mission to Help Make Non Animal Testing Famous, Releases Fiscal 2021 Results

    Placentia, California--(Newsfile Corp. - December 8, 2021) - InVitro International (OTC Pink: IVRO) announced today that fiscal year 2021 sales for the year ending on September 30th topped $1M for the third consecutive year at $1,003,403. Though off 9% for the year, second half sales were up 47% versus the same period last year. Fiscal 2021 net income of $93,522 (including PPP forgiveness of $106,665) was nearly double the fiscal 2020 net income. In addition, IVRO finished fiscal 2021 with...

    2021-12-08 9:00 AM EST
  • InVitro Announces Appointment of Investor Relations Partners

    Placentia, California--(Newsfile Corp. - May 25, 2021) - InVitro International, Inc. (OTC Pink: IVRO) today announced the appointment of Investor Relations Partners (IRP) to provide external investor relations services to InVitro.IRP is an investor relations and public relations firm representing and advising micro to mega market cap companies, with a collective 50+ years of direct capital market experience."With our continued financial improvements, recovering economy and improved regulatory condition, we believe InVitro presents an extremely undervalued investment story that will resonate...

    2021-05-25 8:00 AM EDT